<--- Back to Details
First PageDocument Content
Clinical research / Pharmaceuticals policy / Pharmacology / Pharmaceutical industry / Health Canada / Food and Drug Administration / Health Products and Food Branch / Therapeutic Products Directorate / Drug Identification Number / Medicine / Health / Pharmaceutical sciences
Date: 2013-06-24 11:52:36
Clinical research
Pharmaceuticals policy
Pharmacology
Pharmaceutical industry
Health Canada
Food and Drug Administration
Health Products and Food Branch
Therapeutic Products Directorate
Drug Identification Number
Medicine
Health
Pharmaceutical sciences

Draft Guidnace Document: The Use of Foreign Reviews by Health Canada

Add to Reading List

Source URL: hc-sc.gc.ca

Download Document from Source Website

File Size: 80,79 KB

Share Document on Facebook

Similar Documents

RECORD OF DISCUSSIONS CANADIAN ADVERTISING PRECLEARANCE AGENCIES and HEALTH CANADA Health Protection Building, 200 Tunney’s Pasture Driveway, Ottawa, Room 0218 Tuesday April 22, 2014 – 10:00 a.m. - 12:15 p.m.

RECORD OF DISCUSSIONS CANADIAN ADVERTISING PRECLEARANCE AGENCIES and HEALTH CANADA Health Protection Building, 200 Tunney’s Pasture Driveway, Ottawa, Room 0218 Tuesday April 22, 2014 – 10:00 a.m. - 12:15 p.m.

DocID: 1fGVn - View Document

Santé Health Canada Canada LN/NH:  Therapeutic Products Directorate

Santé Health Canada Canada LN/NH: Therapeutic Products Directorate

DocID: 1eBQp - View Document

Santé Health Canada Canada LN/NH:  Therapeutic Products Directorate

Santé Health Canada Canada LN/NH: Therapeutic Products Directorate

DocID: 1b7vx - View Document

Santé Health Canada Canada LN/NH:  Therapeutic Products Directorate

Santé Health Canada Canada LN/NH: Therapeutic Products Directorate

DocID: Zhov - View Document

Presentation: Regulatory and Policy Updates - Therapeutic Products Directorate - Health Canada

Presentation: Regulatory and Policy Updates - Therapeutic Products Directorate - Health Canada

DocID: HoMl - View Document